Pharma Cultivation ApS
CVR number: 39699370
Hestbækvej 93, Dollerup 9640 Farsø
Ln@pharmacultivation.dk
tel: 40411544
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -39.42 | -36.92 | - 101.32 | 340.35 | 49.31 |
| Employee benefit expenses | - 317.35 | - 545.92 | -1 307.20 | - 907.21 | |
| Other operating expenses | - 659.02 | ||||
| Total depreciation | -12.29 | -14.00 | |||
| EBIT | -39.42 | - 354.27 | - 647.24 | - 979.14 | -1 530.92 |
| Other financial income | 2.57 | 0.28 | 26.15 | ||
| Other financial expenses | -0.22 | -27.79 | -10.44 | -97.94 | - 370.31 |
| Pre-tax profit | -37.06 | - 382.06 | - 657.68 | -1 076.81 | -1 875.09 |
| Income taxes | -1.49 | 201.27 | 895.88 | ||
| Net earnings | -38.56 | - 382.06 | - 657.68 | - 875.54 | - 979.21 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 4 072.19 | 4 571.37 | |||
| Intangible assets total | 4 072.19 | 4 571.37 | |||
| Machinery and equipment | 57.71 | ||||
| Advance payments and construction in progress | 2 594.78 | 2 651.45 | 2 809.02 | ||
| Tangible assets total | 2 594.78 | 2 651.45 | 2 866.73 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 1.84 | 21.80 | 40.06 | ||
| Current other receivables | 9.12 | 664.54 | 32.34 | 121.90 | |
| Current deferred tax assets | 201.27 | ||||
| Short term receivables total | 10.96 | 664.54 | 32.34 | 344.96 | 40.06 |
| Cash and bank deposits | 0.13 | 9.09 | 3.20 | 2.18 | 2.21 |
| Cash and cash equivalents | 0.13 | 9.09 | 3.20 | 2.18 | 2.21 |
| Balance sheet total (assets) | 11.09 | 3 268.41 | 2 687.00 | 7 286.06 | 4 613.65 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 4 072.19 | 4 571.37 | |||
| Retained earnings | -1.97 | -40.52 | - 422.58 | -5 152.45 | -6 527.17 |
| Profit of the financial year | -38.56 | - 382.06 | - 657.68 | - 875.54 | - 979.21 |
| Shareholders equity total | -0.52 | - 382.58 | -1 040.26 | -1 915.80 | -2 895.01 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 0.49 | ||||
| Current trade creditors | 11.25 | 3 155.23 | 2 727.80 | 5 380.79 | 1 107.43 |
| Current owed to participating | 440.55 | 841.76 | |||
| Current owed to group member | 852.96 | ||||
| Other non-interest bearing current liabilities | 0.36 | 55.21 | - 695.74 | 3 821.08 | 6 401.22 |
| Current liabilities total | 11.61 | 3 650.99 | 3 727.25 | 9 201.86 | 7 508.65 |
| Balance sheet total (liabilities) | 11.09 | 3 268.41 | 2 687.00 | 7 286.06 | 4 613.65 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.